Use of antibiotic therapy for recurrent urinary tract infections caused by Escherichia coli
Abstract
Introduction: Urinary tract infections (UTIs) are among the most common infections and a leading reason for antibiotic prescriptions. They are more common in women,
particularly during menopause. The cost of treating urinary tract infections significantly impacts the health system and affects the quality of life, especially when the infections are recurrent. Reinfections account for 80% of recurrent infections, with the primary cause usually being the colon bacterial flora, with Escherichia coli as the dominant culprit.
Case report. A 63-year-old female patient visited her GP with complaints of low-grade fever and frequent urination without dysuria. She was diagnosed with cystitis and was prescribed a seven-day course of antibiotics, which effectively resolved her urinary tract infection symptoms. Due to frequent urinary tract infections, she was subsequently placed on a prophylactic six-month course of nitrofurantoin, 50 mg. The patient remained symptom-free during the antibiotic prophylaxis.
Conclusion. Many protocols have been shown to reduce the occurrence of urinary tract infections. Antibiotic treatment based on the antibiogram, as well as antibiotic prophylaxis (continuous and post-coital), has proven to be the most effective method for preventing recurrent cystitis. The choice of treatment method and approach depends on the frequency and severity of symptoms.
References
Zdravstveno statistički godišnjak Republike Srbije 2022. Institut za javno zdravlje Srbije ,,Dr Milan Jovanović Batut” [cited 2024 March 18] Available from: https://www.batut.org.rs/download/publikacije/pub2022v1.pdf
Bogdanović S, Zlatković I, Zlatanović Z, Ranđelović D, Vacić N. Učestalost uzročnika infekcija urinarnog trakta. PONS Med Č 2022;19(2):62–6. [cited 2024 March 18] doi: 10.5937/pomc19-41863
Nacionalni vodič dobre kliničke prakse. Prevencija i lečenje nekomplikovanih urinarnih infekcija. Ministarstvo zdravlja Republike Srbije, Akademija medicinskih nauka Srpskog lekarskog društva, Republička stručna komisija za nefrologiju i urologiju, Beograd 2022. [cited 2024 March 18] Available from: https://www.zdravlje.gov.rs/view_file.php?file_id=2349&cache=sr
Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, et al. EAU Guidelines on urological infections. European association of urology 2023 [cited 2024 March 18] Available from: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Urological-infections-2023.pdf
Bančević V. Urinarne infekcije - savremeni pristup dijagnostici i lečenju. Galenika Medical Journal 2022;1(4):21–4. [cited 2024 March 21] doi: 10.5937/Galmed2204023B;dec 2022.
Đorđević Z, Folić M, Janković S. Community-acquired urinary tract infections: Causative agents and their resistance to antimicrobial drugs. Vojnosanit Pregl 2016;73(12):1109–15. [cited 2024 March 21] doi: 10.2298/VSP150122218D.
Lazarević J, Nikolić B, Malešević Z, Ninković V. Antibiotska rezistencija uzročnika infekcija urinarnog trakta kod pacijenata Instituta za javno zdravlje Kragujevac. Zdravstvena zaštita 2022;51(2):56–71. [cited 2024 March 21] doi: 10.5937/zdravzast51-36978.
Jelesić Z, Gusman V, Mihajlović Ukropina M, Kulauzov M, Medić D. Rezistencija Escherichiae coli iz fecesa zdravih osoba i iz hrane - indikator nivoa rezistencije na antibiotike u populaciji. Med Pregl 2011;64(7-8):397–402. [cited 2024 March 21] doi: 10.2298/MPNS1108397J.
Lee DS, Lee SJ, Choe HS. Community-acquired urinary tract infection by Escherichia coli in the Era of antibiotic resistance. Biomed Res Int 2018;2018:7656752. [cited 2024 April 01] doi: 10.1155/2018/7656752.
Sharma G, Sharma S, Sharma P, Chandola D, Dang S, Gupta S, Gabrani R. Escherichia coli biofilm: development and therapeutic strategies. J Appl Microbiol 2016;121(2):309–19. [cited 2024 April 01] doi: 10.1111/jam.13078.
Mazicioğlu MM. Fitoterapija - alternativni način lečenja bolesti na naučnoj osnovi. Opšta medicina 2020;26(3-4):96–104. [cited 2024 April 01] doi: 10.5937/opmed2004096M
Bonkat G, Bartoletti R, Bruyére F, Cai T, Geerlings SE, Köves B, et al. EAU Guidelines on Urological Infections. Arnhem: European Association of Urology Guidelines Office, 2022 [cited 2024 April 01] Available from: https://allos.cl/wp-content/uploads/2024/01/EAU-Guidelines-on-Urological-Infections-2022.pdf
Scott AM, Clark J, Del Mar C, Glasziou P. Increased fluid intake to prevent urinary tract infections: systematic review and meta‐analysis. Br J Gen Pract 2020;70(692):e200–7.
González de Llano D, Moreno-Arribas MV, Bartolomé B. Cranberry polyphenols and prevention against urinary tract infections: Relevant considerations. Molecules 2020;25(15):3523. [cited 2024 April 01] doi: 10.3390/molecules25153523.
Ala-Jaakkola R, Laitila A, Ouwehand AC, Lehtoranta L. Role of D-mannose in urinary tract infections - a narrative review. Nutr J 2022;21(1):18. [cited 2024 April 01] doi: 10.1186/s12937-022-00769-x.
Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, et al. Urinary tract infections caused by uropathogenic Escherichia coli: Mechanisms of infection and treatment options. Int J Mol Sci 2023;24(13):10537. [cited 2024 April 01] doi: 10.3390/ijms241310537.
Copyright (c) 2024 Tanja Stefanović, Eva Stojković
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Autori zadržavaju autorska prava nad objavljenim člancima, a izdavaču daju neekskluzivno pravo da članak objavi, da u slučaju daljeg korišćenja članka bude naveden kao njegov prvi izdavač, kao i da distribuira članak u svim oblicima i medijima.